Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025.
- Largest single sale: $1.8M (2,735 shares) of Regeneron Pharmaceuticals on Oct 29, 2025. Filing
- Last sale before this period: Aug 15, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Prudential Financial (PRU) | Director | Sep 5, 2006 | Sep 14, 2026 |
| Neurocrine Biosciences Inc (NBIX) | Director | Jul 13, 2023 | May 29, 2026 |
| Regeneron Pharmaceuticals (REGN) | Director | Nov 15, 2010 | Jan 6, 2026 |
| Sherwin-Williams (SHW) | Former Director | Apr 16, 2014 | Apr 7, 2025 |
| Johnson & Johnson (JNJ) | Former Vice Chairman, Director | Feb 11, 2004 | Feb 17, 2009 |
Also a director at
Neurocrine Biosciences Inc (NBIX), Regeneron Pharmaceuticals (REGN), Sherwin-Williams (SHW) (no filing in the last 18 months), Johnson & Johnson (JNJ) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 10, 2026, Prudential Financial: 161 shares awarded. 1 filing: 1
- Jun 11, 2026, Prudential Financial: 177 shares awarded. 1 filing: 1
- May 21, 2026, Neurocrine Biosciences Inc: 3,318 shares vested. 1 filing: 1
- May 12, 2026, Prudential Financial: 1,765 shares vested; 1,765 shares returned to the company. 1 filing: 1
- Mar 12, 2026, Prudential Financial: 201 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.